StockData
Neogen Corp logo

Neogen Corp (NEOG) stock

NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 7/3049% above fair value
$10.90+0.02 (+0.18%)

Close on Nov 17, 2026Market cap $2.38BP/E –Yield –

Neogen ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Neogen's ebitda for the twelve months ending Aug 31, 2026 was $108.92M. For fiscal 2026 it was $94.70M. Over ten years it grew 3.3% a year on average. The highest annual figure on record is $175.30M in fiscal 2024.

Annual ebitda

PeriodPeriod endValueChange
FY2026May 31, 2026$94.70M–
FY2025May 31, 2025-$941.50M-637.1%
FY2024May 31, 2024$175.30M+39.2%
FY2023May 31, 2023$125.89M+52.9%
FY2022May 31, 2022$82.31M-13.5%
FY2021May 31, 2021$95.21M+10.8%
FY2020May 31, 2020$85.92M+0.2%
FY2019May 31, 2019$85.72M-1.8%
FY2018May 31, 2018$87.25M+9.6%
FY2017May 31, 2017$79.64M+16.1%
FY2016May 31, 2016$68.57M+7.5%
FY2015May 31, 2015$63.77M+21.3%
FY2014May 31, 2014$52.57M+9.3%
FY2013May 31, 2013$48.12M+20.6%
FY2012May 31, 2012$39.91M-3.0%
FY2011May 31, 2011$41.16M+31.5%
FY2010May 31, 2010$31.31M–

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Aug 31, 2026$27.30M+110.0%
Q4 FY2026CQ2 2026May 31, 2026$32.50M–
Q3 FY2026CQ1 2026Feb 28, 2026$25.62M-26.3%
Q2 FY2026CQ4 2025Nov 30, 2025$23.51M–
Q1 FY2026CQ3 2025Aug 31, 2025$13.00M-59.4%
Q4 FY2025CQ2 2025May 31, 2025-$580.90M-1488.9%
Q3 FY2025CQ1 2025Feb 28, 2025$34.75M-16.6%
Q2 FY2025CQ4 2024Nov 30, 2024-$427.44M-1072.9%
Q1 FY2025CQ3 2024Aug 31, 2024$32.06M-33.0%
Q4 FY2024CQ2 2024May 31, 2024$41.82M-19.4%
Q3 FY2024CQ1 2024Feb 29, 2024$41.67M-3.4%
Q2 FY2024CQ4 2023Nov 30, 2023$43.93M+130.2%
Q1 FY2024CQ3 2023Aug 31, 2023$47.87M+306.0%
Q4 FY2023CQ2 2023May 31, 2023$51.86M+117.1%
Q3 FY2023CQ1 2023Feb 28, 2023$43.16M+239.8%
Q2 FY2023CQ4 2022Nov 30, 2022$19.08M+4.3%
Q1 FY2023CQ3 2022Aug 31, 2022$11.79M-57.0%
Q4 FY2022CQ2 2022May 31, 2022$23.89M-8.8%
Q3 FY2022CQ1 2022Feb 28, 2022$12.70M-40.5%
Q2 FY2022CQ4 2021Nov 30, 2021$18.30M-23.9%
Q1 FY2022CQ3 2021Aug 31, 2021$27.43M+16.1%
Q4 FY2021CQ2 2021May 31, 2021$26.19M+5.6%
Q3 FY2021CQ1 2021Feb 28, 2021$21.36M+21.4%
Q2 FY2021CQ4 2020Nov 30, 2020$24.05M+5.4%
Q1 FY2021CQ3 2020Aug 31, 2020$23.62M+14.1%
Q4 FY2020CQ2 2020May 31, 2020$24.80M+6.3%
Q3 FY2020CQ1 2020Feb 29, 2020$17.60M-7.7%
Q2 FY2020CQ4 2019Nov 30, 2019$22.82M+1.1%
Q1 FY2020CQ3 2019Aug 31, 2019$20.70M-0.2%
Q4 FY2019CQ2 2019May 31, 2019$23.33M-3.8%
Q3 FY2019CQ1 2019Feb 28, 2019$19.07M-6.2%
Q2 FY2019CQ4 2018Nov 30, 2018$22.57M+1.3%
Q1 FY2019CQ3 2018Aug 31, 2018$20.75M+1.6%
Q4 FY2018CQ2 2018May 31, 2018$24.24M+5.4%
Q3 FY2018CQ1 2018Feb 28, 2018$20.33M+12.9%
Q2 FY2018CQ4 2017Nov 30, 2017$22.27M+9.1%
Q1 FY2018CQ3 2017Aug 31, 2017$20.42M–
Q4 FY2017CQ2 2017May 31, 2017$23.00M–
Q3 FY2017CQ1 2017Feb 28, 2017$18.00M–
Q2 FY2017CQ4 2016Nov 30, 2016$20.41M–

More Neogen figures

See a number that looks wrong?